A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
Ujjini H. Manjunatha(Novartis (Singapore)), Sumiti Vinayak(University of Georgia), Jennifer A. Zambriski(Washington State University), Alexander T. Chao(Novartis (Singapore)), Tracy Sy(Washington State University), Christian G. Noble(Novartis (Singapore)), Ghislain M. C. Bonamy(Novartis (Singapore)), Ravinder Reddy Kondreddi(Novartis (Singapore)), Bin Zou(Novartis (Singapore)), Peter Gedeck(Novartis (Singapore)), Carrie F. Brooks(University of Georgia), Gillian T. Herbert(University of Georgia), Adam Sateriale(University of Georgia), Jayesh Tandel(University of Georgia), Susan M. Noh(Washington State University), Suresh B. Lakshminarayana(Novartis (Singapore)), Siau Hoi Lim(Novartis (Singapore)), Laura B. Goodman(New York State College of Veterinary Medicine), Christophe Bodenreider(Novartis (Singapore)), Feng Gu(Novartis (Singapore)), Lijun Zhang(Novartis (China)), Francesca Blasco(Novartis (Singapore)), Juergen Wagner(Novartis (Singapore)), F. Joel Leong(Novartis (Singapore)), Boris Striepen(University of Georgia), Thierry T. Diagana(Novartis (Singapore))
Cited by 199Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis